Gaspare Mura

Open Bionics: Open Bionics is a prosthetics company developing affordable, assistive devices that enhance the human body. Weve started by introducing the Hero Arm, a stylish multi-grip bionic arm. Current upper limb prostheses exist as hooks, grippers, or expensive bionic hands. Were on a mission to make beautiful bionic limbs more accessible. Aged 17, Joel Gibbard began tinkering with robotic hands. There was something about the movement of a disembodied humanoid hand that captured his imagination. Hundreds of prototypes and many crates of failures later, in 2014, Joel co-founded Open Bionics with Samantha Payne. With the help of an awesome team and the support of the limb different community, they’re pioneering a new bionic age inspired by science fiction. www.openbionics.com The Hero Arm: The Hero Arm is Open Bionics​ first commercially available bionic limb. The Hero Arm is the most affordable multi-grip bionic arm ever, less than half the price of its nearest competitor. Each Hero Arm is custom-built, and for the first time ever is available for upper limb amputees as young as nine.

Antler is one of the most active early-stage investors globally. The firm leads in ‘Day Zero’ investing, an approach to venture capital focused on partnering with founders pre-launch. Antler systematically removes capital and network constraints for early-stage technology entrepreneurs by providing co-founder matching, deep business model validation, initial capital, expansion support, and follow-on funding. The firm is present in 27 cities across most leading technology ecosystems globally and has made over 1,300 investments into early-stage startups. Antler has been repeatedly recognized by Pitchbook as the world’s most active angel and seed-stage investor.

Open Bionics: Open Bionics is a prosthetics company developing affordable, assistive devices that enhance the human body. Weve started by introducing the Hero Arm, a stylish multi-grip bionic arm. Current upper limb prostheses exist as hooks, grippers, or expensive bionic hands. Were on a mission to make beautiful bionic limbs more accessible. Aged 17, Joel Gibbard began tinkering with robotic hands. There was something about the movement of a disembodied humanoid hand that captured his imagination. Hundreds of prototypes and many crates of failures later, in 2014, Joel co-founded Open Bionics with Samantha Payne. With the help of an awesome team and the support of the limb different community, they’re pioneering a new bionic age inspired by science fiction. www.openbionics.com The Hero Arm: The Hero Arm is Open Bionics​ first commercially available bionic limb. The Hero Arm is the most affordable multi-grip bionic arm ever, less than half the price of its nearest competitor. Each Hero Arm is custom-built, and for the first time ever is available for upper limb amputees as young as nine.

The first decision support system for pharmacists NfXFarma reduces the uncertainty and stress of managing your pharmacy while increasing the success of your business. NfXFarma understands the complexities of your business operations, provides real-time recommendations, autonomously executes actions and continuously evolves through the insights gained from each decision made

IQVIA (NYSE:IQV) is a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries. IQVIA’s portfolio of solutions are powered by IQVIA Connected Intelligence™ to deliver actionable insights and services built on high-quality health data, Healthcare-grade AI™, advanced analytics, the latest technologies and extensive domain expertise. With approximately 88,000 employees in over 100 countries, including experts in healthcare, life sciences, data science, technology and operational excellence, IQVIA is dedicated to accelerating the development and commercialization of innovative medical treatments to help improve patient outcomes and population health worldwide. IQVIA is a global leader in protecting individual patient privacy. The company uses a wide variety of privacy-enhancing technologies and safeguards to protect individual privacy while generating and analyzing information on a scale that helps healthcare stakeholders identify disease patterns and correlate with the precise treatment path and therapy needed for better outcomes. IQVIA’s insights and execution capabilities help biotech, medical device and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders tap into a deeper understanding of diseases, human behaviors and scientific progress, in an effort to advance healthcare. To learn more, visit www.iqvia.com.

We are a global public relations agency that helps companies create change that matters. Our people help us do the best work of our lives for our clients. Work that earns attention and showcases the power of collaboration. Golin was proudly named in PRWeek’s Global Agency of the Year in 2025, U.S. 2024 Agency of the Year, 2022 Best Places to Work, PRovoke Media’s 2021 North American Large Agency of the Year and listed to the Chicago Tribune’s Top Workplaces in 2021.